Dale Greiner to Antigens, Differentiation
This is a "connection" page, showing publications Dale Greiner has written about Antigens, Differentiation.
Connection Strength
0.279
-
Iwakoshi NN, Mordes JP, Markees TG, Phillips NE, Rossini AA, Greiner DL. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner. J Immunol. 2000 Jan 01; 164(1):512-21.
Score: 0.167
-
Zheng XX, Markees TG, Hancock WW, Li Y, Greiner DL, Li XC, Mordes JP, Sayegh MH, Rossini AA, Strom TB. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment. J Immunol. 1999 Apr 15; 162(8):4983-90.
Score: 0.040
-
Markees TG, Phillips NE, Gordon EJ, Noelle RJ, Shultz LD, Mordes JP, Greiner DL, Rossini AA. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4. J Clin Invest. 1998 Jun 01; 101(11):2446-55.
Score: 0.037
-
Chen-Woan M, Greiner DL. Mechanisms of allograft prolongation in RT6 T cell-depleted rats. Transplant Proc. 1991 Feb; 23(1 Pt 1):143-6.
Score: 0.023
-
Kosuda LL, Greiner DL, Bigazzi PE. Mercury-induced renal autoimmunity in BN-->LEW.1N chimeric rats. Cell Immunol. 1994 Apr 15; 155(1):77-94.
Score: 0.007
-
Woda BA, Handler ES, Greiner DL, Reynolds C, Mordes JP, Rossini AA. T-lymphocyte requirement for diabetes in RT6-depleted diabetes-resistant BB rats. Diabetes. 1991 Apr; 40(4):423-8.
Score: 0.006